Edwards Lifesciences (EW) Net Margin Growth (3y) (2012 - 2025)
Edwards Lifesciences (EW) Net Margin Growth (3y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.71 Bn | 194.11 Bn | 7.27 Bn | -641.00 |
| 2 | Stryker | 129.50 Bn | 126.03 Bn | 4.50 Bn | 459.00 |
| 3 | Medtronic | 119.85 Bn | 110.63 Bn | 6.41 Bn | -108.00 |
| 4 | Boston Scientific | 73.79 Bn | 73.25 Bn | 3.85 Bn | 941.00 |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | -1,024.00 |
| 6 | Dexcom | 34.58 Bn | 32.64 Bn | 830.00 Mn | 574.00 |
| 7 | GE HealthCare Technologies | 34.14 Bn | 32.03 Bn | 2.18 Bn | 216.00 |
| 8 | Koninklijke Philips | 26.45 Bn | 23.13 Bn | 4.55 Bn | 647.00 |
| 9 | Steris | 23.23 Bn | 22.74 Bn | 684.20 Mn | 300.00 |
| 10 | Zimmer Biomet Holdings | 19.35 Bn | 18.94 Bn | 1.54 Bn | -206.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -9,095.00 |
| Sep 30, 2025 | -2,617.00 |
| Jun 30, 2025 | -2,987.00 |
| Mar 31, 2025 | -2,837.00 |
| Dec 31, 2024 | -2,238.00 |
| Sep 30, 2024 | 17,393.00 |
| Jun 30, 2024 | -3,550.00 |
| Mar 31, 2024 | -2,584.00 |
| Dec 31, 2023 | -2,308.00 |
| Sep 30, 2023 | -2,458.00 |
| Jun 30, 2023 | 1,741.00 |
| Mar 31, 2023 | 36.00 |
| Dec 31, 2022 | 6,881.00 |
| Sep 30, 2022 | 93.00 |
| Jun 30, 2022 | 729.00 |
| Mar 31, 2022 | 271.00 |
| Dec 31, 2021 | 2,450.00 |
| Sep 30, 2021 | 104.00 |
| Jun 30, 2021 | 562.00 |
| Mar 31, 2021 | 471.00 |